Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine

Jonathan G. Stine, Michelle T. Long, Kathleen E. Corey, Robert E. Sallis, Alina M. Allen, Matthew J. Armstrong, David E. Conroy, Daniel J. Cuthbertson, Andres Duarte-Rojo, Kate Hallsworth, Ingrid J. Hickman, Matthew R. Kappus, Shelley E. Keating, Christopher J.A. Pugh, Yaron Rotman, Tracey L. Simon, Eduardo Vilar-Gomez, Vincent Wai Sun Wong, Kathryn H. Schmitz

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Although physical activity (PA) is crucial in the prevention and clinical management of nonalcoholic fatty liver disease, most individuals with this chronic disease are inactive and do not achieve recommended amounts of PA. There is a robust and consistent body of evidence highlighting the benefit of participating in regular PA, including a reduction in liver fat and improvement in body composition, cardiorespiratory fitness, vascular biology, and health-related quality of life. Importantly, the benefits of regular PA can be seen without clinically significant weight loss. At least 150 min of moderate or 75 min of vigorous intensity PA are recommended weekly for all patients with nonalcoholic fatty liver disease, including those with compensated cirrhosis. If a formal exercise training program is prescribed, aerobic exercise with the addition of resistance training is preferred. In this roundtable document, the benefits of PA are discussed, along with recommendations for 1) PA assessment and screening; 2) how best to advise, counsel, and prescribe regular PA; and 3) when to refer to an exercise specialist.

Original languageEnglish (US)
Pages (from-to)1717-1726
Number of pages10
JournalMedicine and science in sports and exercise
Issue number9
StatePublished - Sep 1 2023

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this